Market Overview:
The global pneumonia diagnostic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of pneumonia, rising demand for accurate and rapid diagnosis, and technological advancements in diagnostics. Based on type, the global pneumonia diagnostic market is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, and Mycoplasma Pneumonia-based segments. The Streptococcus-based segment is expected to account for the largest share of the global pneumonia diagnostic market in 2018 owing to factors such as high prevalence of streptococcal infections and growing demand for strep tests. By application, hospitals are expected to account for the largest share of the global pneumonia diagnostic market in 2018 owing to factors such as rising number of hospital admissions due to respiratory diseases and increasing awareness about early diagnosis and treatment options.
Product Definition:
Pneumonia Diagnostics is a test that is used to diagnose pneumonia. This test can help to determine the cause of the pneumonia and how severe it may be.
Streptococcus-based:
The global streptococcus-based, it's usage and growth factor in pneumonia diagnostic market size was valued at USD 4.5 billion in 2015 and is expected to grow with CAGR of XX% over the forecast period. Increasing prevalence of pneumococcal disease globally is one of the key drivers for this market’s growth over the coming years.
Legionella-based:
Legionella is a type of pneumonia caused by bacteria. It is one of the leading causes of pneumonic infection in the U.S., Europe, and Japan. According to CDC, around 2-10% adults and children get infected with this disease every year in the U.S., resulting in about 20,000 hospitalizations and 80 deaths per year on average (50% male patients).
Application Insights:
Based on the application, the global pneumonia diagnostic market is segmented into hospitals, clinics, diagnostic centers and others. Hospitals held the largest share in 2017 owing to factors such as a large patient base and high prevalence of chronic diseases. In addition, hospitals are considered to be one of the most advanced healthcare facilities due to their capability for providing critical care services. This factor is anticipated to drive demand over the forecast period.
Clinics are expected to witness lucrative growth over next six years owing to increasing awareness regarding early diagnosis coupled with rising investment by government bodies in improving healthcare infrastructure across various regions globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, increasing awareness about Pneumonia Diagnosis, and availability of advanced diagnostic technologies. In addition, rising incidence rate of infectious diseases is also anticipated to drive growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing penetration of medical practitioners in rural areas & remote places where access to advanced diagnostics are not available currently.
Growth Factors:
- Increasing incidence of pneumonia across the globe
- Rising demand for point-of-care diagnostics for early diagnosis and treatment of pneumonia
- Growing awareness about pneumococcal vaccination among people to prevent the disease
- Technological advancements in diagnostic techniques for accurate diagnosis of pneumonia 5. Emergence of novel biomarkers for detection and management of pneumonia
Scope Of The Report
Report Attributes
Report Details
Report Title
Pneumonia Diagnostic Market Research Report
By Type
Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based
By Application
Hospitals, Clinics, Diagnostic Centres, Others
By Companies
Abbott, Glaxo Smith Kline, Affymetrix, Becton Dickinson, BioMerieux, Cepheid, Diamedix/Erba
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Pneumonia Diagnostic Market Report Segments:
The global Pneumonia Diagnostic market is segmented on the basis of:
Types
Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centres, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Glaxo Smith Kline
- Affymetrix
- Becton Dickinson
- BioMerieux
- Cepheid
- Diamedix/Erba
Highlights of The Pneumonia Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Streptococcus-based
- Legionella-based
- Chlamydophila-based
- Viral Pneumonia-based
- Mycoplasma Pneumonia-based
- By Application:
- Hospitals
- Clinics
- Diagnostic Centres
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pneumonia Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pneumonia is an infection of the lungs. It can be caused by a number of different things, including bacteria, viruses, and fungi. The most common type of pneumonia is caused by the bacterium Streptococcus pneumoniae.
Some of the key players operating in the pneumonia diagnostic market are Abbott, Glaxo Smith Kline, Affymetrix, Becton Dickinson, BioMerieux, Cepheid, Diamedix/Erba.
The pneumonia diagnostic market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pneumonia Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pneumonia Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pneumonia Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pneumonia Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pneumonia Diagnostic Market Size & Forecast, 2020-2028
4.5.1 Pneumonia Diagnostic Market Size and Y-o-Y Growth
4.5.2 Pneumonia Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Streptococcus-based
5.2.2 Legionella-based
5.2.3 Chlamydophila-based
5.2.4 Viral Pneumonia-based
5.2.5 Mycoplasma Pneumonia-based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centres
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pneumonia Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pneumonia Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Streptococcus-based
9.6.2 Legionella-based
9.6.3 Chlamydophila-based
9.6.4 Viral Pneumonia-based
9.6.5 Mycoplasma Pneumonia-based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centres
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Streptococcus-based
10.6.2 Legionella-based
10.6.3 Chlamydophila-based
10.6.4 Viral Pneumonia-based
10.6.5 Mycoplasma Pneumonia-based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centres
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Streptococcus-based
11.6.2 Legionella-based
11.6.3 Chlamydophila-based
11.6.4 Viral Pneumonia-based
11.6.5 Mycoplasma Pneumonia-based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centres
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Streptococcus-based
12.6.2 Legionella-based
12.6.3 Chlamydophila-based
12.6.4 Viral Pneumonia-based
12.6.5 Mycoplasma Pneumonia-based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centres
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Streptococcus-based
13.6.2 Legionella-based
13.6.3 Chlamydophila-based
13.6.4 Viral Pneumonia-based
13.6.5 Mycoplasma Pneumonia-based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centres
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pneumonia Diagnostic Market: Competitive Dashboard
14.2 Global Pneumonia Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Glaxo Smith Kline
14.3.3 Affymetrix
14.3.4 Becton Dickinson
14.3.5 BioMerieux
14.3.6 Cepheid
14.3.7 Diamedix/Erba
